THE ROLE OF TREFOIL FACTOR 3 IN MEDIATING RESISTANCE TOWARDS HER2-TARGETED DRUGS IN BREAST CANCER
Ph.D
Saved in:
Main Author: | CHONG QING YUN |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2017
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/135089 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma
by: Chong, Q.-Y, et al.
Published: (2020) -
Brain metastases in Asian HER2-positive breast cancer patients: Anti-HER2 treatments and their impact on survival
by: Yap, Y.S., et al.
Published: (2014) -
Serum estrogen receptor bioactivity and breast cancer risk among postmenopausal women
by: Lim, V.W., et al.
Published: (2014) -
PHARMACOLOGICAL INHIBITION OF TFF3 ENHANCES SENSITIVITY-AND OVERCOMES ACQUIRED RESISTANCE-TO DOXORUBICIN IN ESTROGEN RECEPTOR-POSITIVE BREAST CANCER
by: POH HAN MING
Published: (2020) -
THE ROLE OF AUTOCRINE HUMAN GROWTH HORMONE (HGH) IN HER2+ BREAST CARCINOMA CELLS
by: LAU YONG CHEN AMY
Published: (2015)